CLINICAL ROLE -
Health Care Disparities Reduced Under ACA
Insurance coverage and use of care improves among minorities following reform.
Read More
Overcoming High Copay Costs
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how specialty pharmacies can help patients manage increasing copay costs.
Genetics Research May Lead to Superior IBD Treatments
There may be several different disorders within Crohn's disease and ulcerative colitis.
Viral Hepatitis and Liver Cancer Development
Researchers seek a better understanding of the mechanism behind hepatocellular carcinoma.
Employers Seek to Halt Rising Specialty Drug Costs
Aggressive new approaches considered to curb financial hit from prescription drugs.
Global Immunology Treatment Market Forecast to Decline Long-Term
Revenue not expected to maintain pace of current immunology treatments.
Medicare Not Helping Chemo Drug Cost Tops Specialty Pharmacy Week in Review
Catch up with the most read articles of the week on Specialty Pharmacy Times.
Amgen Submits Application to FDA for Humira Biosimilar
Submission bolstered by trials evaluating biosimilar candidate in moderate-to-severe plaque psoriasis and rheumatoid arthritis.
Age of Patients Influences Breast Cancer Drug Side Effects
Severity and type of symptoms varies among cancer patients in different age groups.
Medicare Does Little to Alleviate High Cost of Oral Chemotherapy Drugs
Out-of-pocket costs to remain a significant hurdle for patients even after closing of coverage gap.
Will Independent Specialty Pharmacies Disappear in the Future?
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses the trend of larger entities absorbing independent specialty pharmacies.
FDA Approves New Therapy for Leukemia
Bendeka was approved for indolent B-cell non-Hodgkin lymphoma that progressed during or within 6 months of treatment with a rituximab regimen.
Benefits of Early Treatment Outweigh Risk in HIV Patients
Researchers weigh risk and reward in starting early antiretroviral therapy in patients with HIV.
Krypolis Regimen Extends Progression Free Survival in Multiple Myeloma
Trial data shows positive results across a range of difficult-to-treat patients with MM.
Optimizing Management of Specialty Drug Costs
Amy Grogg, PharmD, senior vice president of Strategy and Commercialization at AmerisourceBergen Specialty Group, discusses developing trends in specialty drug cost management.
Researchers Accelerate Hepatitis C Vaccine Search
An HCV vaccine, while elusive, offers the best hope to eradicate the virus.
Can Effective New Drugs Make Organs from HCV-Infected Patients Viable for Transplants?
Researchers consider the ramifications of using organs from infected patients to save lives.
Lung Cancer Drug Granted Accelerated Approval
New treatment option for patients who no longer respond to Xalkori.
Antiviral Drugs Could Cut Hepatitis C Prevalence by 80 Percent
Enhanced screening and treatment in high-risk populations could eliminate virus.
Advances in Cancer Drug Development Highlights Specialty Pharmacy Week in Review
Top stories of the week on Specialty Pharmacy Times.
Scientists May Have Solved Mystery of Multiple Myeloma Relapse
Researchers target how cancer cells avoid treatment.
National Health Care Spending Growth Slows Under ACA
CMS report shows spending rates are lower compared with the years prior to health care reform.
Experimental Leukemia Drug Shows High Response Rates
Treatment shows clinically meaningful reduction in the number of cancer cells in patients with relapsed or refractory chronic lymphocytic leukemia.
Novel Targeted Therapy Improves Survival in Acute Myeloid Leukemia
Addition of midostaurin to chemotherapy shows promise in patients with AML.
FDA Approves Treatment for Lysosomal Acid Lipase Deficiency
Rare disease can cause serious liver and cardiovascular conditions.
Multiple Myeloma Drug Combination Improves Overall Survival
Addition of bortezomib to lenalidomide and low-dose dexamethasone therapy extends disease control.
What Causes Natural Suppression of Hepatitis C Virus?
Researchers determine how the liver is able to naturally inhibit HCV infection.
Novel Diabetes Immunotherapy Deemed Safe in First Trial
Potentially game changing drug may alter diabetes disease course.
Affordable Care and Specialty Pharmacy
David Lassen, chief clinical officer at Prime Therapeutics, discusses implications for specialty pharmacy from health care reform.